Age-related impairment of endothelial progenitor cell migration correlates with structural alterations of heparan sulfate proteoglycans

Aging Cell

Volumn 12, Issue 1, 2013, Pages 139-147

  Williamson, Kate A ^a   Hamilton, Andrew ^a   Reynolds, John A ^a   Sipos, Peter ^a   Crocker, Ian ^a   Stringer, Sally E ^a   Alexander, Yvonne M ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Age; Endothelial progenitor cells; Heparan sulfate

Indexed keywords

HEPARAN SULFATE; POLYSACCHARIDE; PROTEOGLYCAN; URONIC ACID; VASCULOTROPIN;

AGING; ARTICLE; CARBOHYDRATE ANALYSIS; CELL FUNCTION; CELL ISOLATION; CELL MIGRATION; CELL SURFACE; DISEASE COURSE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL PROGENITOR CELL; HUMAN; HUMAN CELL; OVERGROWTH ENDOTHELIAL CELL; PRIORITY JOURNAL; SULFATION; VASCULAR DISEASE;

AGE FACTORS; APOPTOSIS; BLOOD CELLS; CELL GROWTH PROCESSES; CELL MOVEMENT; CELL SURVIVAL; ENDOTHELIAL CELLS; FETAL BLOOD; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; LONGEVITY; STEM CELLS;

EID: 84872523789     PISSN: 14749718     EISSN: 14749726     Source Type: Journal    
DOI: 10.1111/acel.12031     Document Type: Article

References (40)

1. Abbott JD, Huang Y, Liu D, Hickey R, Krause DS, Giordano FJ (2004) Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 110, 3300-5.
2. Broekhuizen LN, Mooij HL, Kastelein JJ, Stroes ES, Vink H, Nieuwdorp M (2009) Endothelial glycocalyx as potential diagnostic and therapeutic target in cardiovascular disease. Curr. Opin. Lipidol. 20, 57-62.
3. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME, Capla JM, Galiano RD, Levine JP, Gurtner GC (2004) Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat. Med. 10, 858-64.
4. Chen E, Stringer SE, Rusch MA, Selleck SB, Ekker SC (2005) A unique role for 6-O sulfation modification in zebrafish vascular development. Dev. Biol. 284, 364-76.
5. Deakin JA, Lyon M (2008) A simplified and sensitive fluorescent method for disaccharide analysis of both heparan sulfate and chondroitin/dermatan sulfates from biological samples. Glycobiology 18, 483-91.
6. Edelberg JM, Tang L, Hattori K, Lyden D, Rafii S (2002) Young adult bone marrow-derived endothelial precursor cells restore aging-impaired cardiac angiogenic function. Circ. Res. 90, E89-93.
7. Fadini GP, Losordo D, Dimmeler S (2012) Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use. Circ. Res. 110, 624-37.
8. Frescaline G, Bouderlique T, Huynh MB, Papy-Garcia D, Courty J, Albanese P (2012) Glycosaminoglycans mimetics potentiate the clonogenicity, proliferation, migration and differentiation properties of rat mesenchymal stem cells. Stem Cell Res. 8, 180-92.
9. Gengrinovitch S, Berman B, David G, Witte L, Neufeld G, Ron D (1999) Glypican-1 is a VEGF165 binding proteoglycan that acts as an extracellular chaperone for VEGF165. J. Biol. Chem. 274, 10816-22.
10. George AL, Bangalore-Prakash P, Rajoria S, Suriano R, Shanmugam A, Mittelman A, Tiwari RK (2011) Endothelial progenitor cell biology in disease and tissue regeneration. J. Hematol. Oncol. 4, 24.
11. Gulati R, Jevremovic D, Peterson TE, Chatterjee S, Shah V, Vile RG, Simari RD (2003) Diverse origin and function of cells with endothelial phenotype obtained from adult human blood. Circ. Res. 93, 1023-5.
12. Heiss C, Keymel S, Niesler U, Ziemann J, Kelm M, Kalka C (2005) Impaired progenitor cell activity in age-related endothelial dysfunction. J. Am. Coll. Cardiol. 45, 1441-8.
13. Hirschi KK, Ingram DA, Yoder MC (2008) Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler. Thromb. Vasc. Biol. 28, 1584-95.
14. Hur J, Yoon CH, Kim HS, Choi JH, Kang HJ, Hwang KK, Oh BH, Lee MM, Park YB (2004) Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler. Thromb. Vasc. Biol. 24, 288-93.
15. Ingram DA, Mead LE, Tanaka H, Meade V, Fenoglio A, Mortell K, Pollok K, Ferkowicz MJ, Gilley D, Yoder MC (2004) Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 104, 2752-60.
16. Kalka C, Masuda H, Takahashi T, Gordon R, Tepper O, Gravereaux E, Pieczek A, Iwaguro H, Hayashi SI, Isner JM, Asahara T (2000) Vascular endothelial growth factor(165) gene transfer augments circulating endothelial progenitor cells in human subjects. Circ. Res. 86, 1198-202.
17. Lin Y, Chang L, Solovey A, Healey JF, Lollar P, Hebbel RP (2002) Use of blood outgrowth endothelial cells for gene therapy for hemophilia A. Blood 99, 457-62.
18. Lindahl U, Backstrom G, Thunberg L, Leder IG (1980) Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin. Proc. Natl Acad. Sci. USA 77, 6551-5.
19. Medina RJ, O'neill CL, Humphreys MW, Gardiner TA, Stitt AW (2010) Outgrowth endothelial cells: characterization and their potential for reversing ischemic retinopathy. Invest. Ophthalmol. Vis. Sci. 51, 5906-13.
20. Melero-Martin JM, Khan ZA, Picard A, Wu X, Paruchuri S, Bischoff J (2007) In vivo vasculogenic potential of human blood-derived endothelial progenitor cells. Blood 109, 4761-8.
21. Mukai N, Akahori T, Komaki M, Li Q, Kanayasu-Toyoda T, Ishii-Watabe A, Kobayashi A, Yamaguchi T, Abe M, Amagasa T, Morita I (2008) A comparison of the tube forming potentials of early and late endothelial progenitor cells. Exp. Cell Res. 314, 430-40.
22. Netelenbos T, van den Born J, Kessler FL, Zweegman S, Huijgens PC, Drager AM (2003) In vitro model for hematopoietic progenitor cell homing reveals endothelial heparan sulfate proteoglycans as direct adhesive ligands. J. Leukoc. Biol. 74, 1035-44.
23. Ono K, Hattori H, Takeshita S, Kurita A, Ishihara M (1999) Structural features in heparin that interact with VEGF165 and modulate its biological activity. Glycobiology 9, 705-11.
24. Prokoph S, Chavakis E, Levental KR, Zieris A, Freudenberg U, Dimmeler S, Werner C (2012) Sustained delivery of SDF-1alpha from heparin-based hydrogels to attract circulating pro-angiogenic cells. Biomaterials 33, 4792-800.
25. Rauscher FM, Goldschmidt-Clermont PJ, Davis BH, Wang T, Gregg D, Ramaswami P, Pippen AM, Annex BH, Dong C, Taylor DA (2003) Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 108, 457-63.
26. Richardson MR, Yoder MC (2011) Endothelial progenitor cells: quo vadis? J. Mol. Cell. Cardiol. 50, 266-72.
27. Robinson CJ, Mulloy B, Gallagher JT, Stringer SE (2006) VEGF165-binding sites within heparan sulfate encompass two highly sulfated domains and can be liberated by K5 lyase. J. Biol. Chem. 281, 1731-40.
28. Ruhrberg C, Gerhardt H, Golding M, Watson R, Ioannidou S, Fujisawa H, Betsholtz C, Shima DT (2002) Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis. Genes Dev. 16, 2684-98.
29. Sadir R, Baleux F, Grosdidier A, Imberty A, Lortat-Jacob H (2001) Characterization of the stromal cell-derived factor-1alpha-heparin complex. J. Biol. Chem. 276, 8288-96.
30. Sarrazin S, Lamanna WC, Esko JD (2011) Heparan sulfate proteoglycans. Cold Spring Harb. Perspect. Biol. 3, 1-34.
31. Scheubel RJ, Zorn H, Silber RE, Kuss O, Morawietz H, Holtz J, Simm A (2003) Age-dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting. J. Am. Coll. Cardiol. 42, 2073-80.
32. Soker S, Svahn CM, Neufeld G (1993) Vascular endothelial growth factor is inactivated by binding to alpha 2-macroglobulin and the binding is inhibited by heparin. J. Biol. Chem. 268, 7685-91.
33. Ungvari Z, Kaley G, de Cabo R, Sonntag WE, Csiszar A (2010) Mechanisms of vascular aging: new perspectives. J. Gerontol. A Biol. Sci. Med. Sci. 65, 1028-41.
34. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, Zeiher AM, Dimmeler S (2001) Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ. Res. 89, E1-7.
35. Walter DH, Haendeler J, Reinhold J, Rochwalsky U, Seeger F, Honold J, Hoffmann J, Urbich C, Lehmann R, Arenzana-Seisdesdos F, Aicher A, Heeschen C, Fichtlscherer S, Zeiher AM, Dimmeler S (2005) Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease. Circ. Res. 97, 1142-51.
36. Wasteson A (1971) A method for the determination of the molecular weight and molecular-weight distribution of chondroitin sulphate. J. Chromatogr. 59, 87-97.
37. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Bohm M, Nickenig G (2005) Circulating endothelial progenitor cells and cardiovascular outcomes. N. Engl. J. Med. 353, 999-1007.
38. Xia WH, Yang Z, Xu SY, Chen L, Zhang XY, Li J, Liu X, Qiu YX, Shuai XT, Tao J (2012) Age-related decline in reendothelialization capacity of human endothelial progenitor cells is restored by shear stress. Hypertension 59, 1225-31.
39. Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, Li F, Krasich R, Temm CJ, Prchal JT, Ingram DA (2007) Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 109, 1801-9.
40. Zhao W, Mccallum SA, Xiao Z, Zhang F, Linhardt RJ (2012) Binding affinities of vascular endothelial growth factor (VEGF) for heparin-derived oligosaccharides. Biosci. Rep. 32, 71-81.